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TABLE 1 3-T CMR Data
3-T CMR (Day 3 Post-MI) Vehicle NCHDL HyCHDL
Functional parameters
LV ejection fraction 43.7  2.2 48.0  2.7 43.4  1.4
LV end-diastolic
volume
100.1  5.5 85.4  1.2* 104.8  3.6
LV end-systolic
volume
56.8  4.6 44.3  2.3* 59.1  1.3
Stroke volume 43.3  1.9 41.0  2.4 45.7  2.9
Anatomic parameters
Area-at-risk, g LV 21.3  1.4 18.1  1.2 20.1  1.1
LV mass, g 73.2  2.9 74.7  2.7 81.6  6.3
Infarct size, % LV 23.3  1.8 13.8  1.3* 19.2  1.0
Infarct mass, g LV 17.4  1.2 10.3  1.1* 15.4  0.7
Myocardial salvage 3.9  0.5 7.8  0.9* 4.7  1.0
Myocardial salvage
index
0.18  0.02 0.43  0.04* 0.23  0.04
Hemorrhage, g LV 2.0  0.3 2.0  0.4 2.4  0.4
No-reﬂow, g LV 2.5  0.2 1.9  0.1* 3.1  0.4
Values are mean  SEM. *p < 0.05 vs. vehicle and animals infused with high-
density lipoprotein isolated from hypercholesterolemic-fed pigs (HyCHDL).
CMR ¼ cardiac magnetic resonance; LV ¼ left ventricle/ventricular;
MI ¼myocardial infarction; NCHDL ¼ animals infused high-density lipoprotein from
normocholesterolemic-fed pigs.
Letters J A C C V O L . 6 6 , N O . 2 1 , 2 0 1 5
D E C E M B E R 1 , 2 0 1 5 : 2 4 6 7 – 7 3
2470(4), and HDL-raising therapies in CVD patients
have yielded disappointing results (5). Further
studies are warranted to fully characterize HDL
functionality and structural remodeling in different
clinical conditions.*Gemma Vilahur, PhD
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2089–99.Understanding the
Mechanism of T-Wave
Inversion in Athletes
May Be Key to Best
ManagementWe read with great interest the recent paper by
Zaidi et al. (1) demonstrating that T-wave inversion
(TWI) in the precordial leads is a nonspeciﬁc ﬁnding
in asymptomatic athletes and that other parameters
have to be evaluated before diagnosing arrhythmo-
genic right ventricular cardiomyopathy (ARVC). This
is not so surprising given the century-old observa-
tions of Swedish physician Henschen that the car-
diac apex is laterally displaced in athletes, thereby
also inferring displacement of the right ventricle
relative to standardized electrocardiography lead
positions. Using magnetic resonance imaging, we
recently validated this observation by demonstrating
that TWI in leads V1 through V4 was determined by
the position rather than morphology of the right
ventricle (2). Thus, we agree that TWI can be
explained by factors other than right ventricular
(RV) pathology in a majority of asymptomatic
athletes.
However, precordial TWI should raise the suspi-
cion of ARVC, especially in endurance athletes
such as cyclists and triathletes. We coined the term
“exercise-induced ARVC” after observing that a
majority of athletes presenting for investigation of
arrhythmias met task force criteria for ARVC
despite the fact that evidence of an inherited syn-
drome was absent in the vast majority (3,4). Pre-
cordial TWI was present in 39% to 71% of those
athletes, and, hence, is an important ﬁrst-line
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2471ﬁnding to trigger further evaluation. Many of the
indicators of RV pathology mentioned by Zaidi
et al. corroborate the initial and ensuing reports of
our group on this entity that detailed the pheno-
typic overlap between an athlete’s heart and ARVC.
As we recently demonstrated, differentiating be-
tween these entities may be far more complex than
electrocardiographic assessment and may even
require careful assessment of RV function during
exercise (5).*André La Gerche, MD, PhD
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T-Wave Inversion in Athletes May Be Key to
Best ManagementWe are grateful to Dr. La Gerche and colleagues
for their interest in our paper (1). They cite
their recent study that presents an intriguing
anatomic explanation for T-wave inversion (TWI) in
athletes, namely, that training-induced lateral
cardiac displacement presents a greater proportionof the right ventricle to the anterior precordial elec-
trocardiography leads, creating negative repolariza-
tion potentials (2). Although this hypothesis has merit
from the perspective of vector cardiography, it seems
unlikely that cardiac rotation alone should account for
the spectrum of repolarization changes in athletic in-
dividuals. The authors illustrate their hypothesis with
an example of marked lateral cardiac displacement in
an athlete, yet the corresponding electrocardiogram
reveals only very subtle T-wave changes. This is in
stark contrast with the deep TWI, often in excess
of 0.5 mV, that is frequently present in healthy
athletes. Additionally, one should not discount
completely the potential role of the left ventricle,
which may constitute 5 times the mass of the right
ventricle in some athletes, in the genesis of T-wave
changes. The similarity between TWI in endurance
athletes and patients presenting with acute anterior
myocardial infarction is remarkable; we previously
demonstrated left ventricular wall thickness to be an
independent predictor of TWI in athletes (3).
Perhaps the most persuasive argument against
a simple mechanical explanation for TWI can be
found in the 14% of African and Afro-Caribbean
athletes who reveal deep anterior TWI (3,4). It
seems unlikely that lateral cardiac displacement
should account for this striking anomaly in so many
cases. We previously documented right ventricular
(RV) dimensions to be similar in black and Cauca-
sian athletes and found no association between
RV size and TWI (4). The aforementioned study
from La Gerche’s group supports the latter ﬁnding;
therefore, it is difﬁcult to understand the proposed
mechanism behind training-induced lateral cardiac
displacement if not driven by ventricular enlarge-
ment. The associations between athletic activity,
cardiac rotation, and anterior TWI reported by La
Gerche et al. require corroboration in longitudinal
studies of athletes in various states of detraining
before any causal relationships can be inferred.
We agree entirely that anterior TWI in the context
of sinister cardiovascular symptoms should raise
suspicion of primary or indeed exercise-induced
arrhythmogenic RV cardiomyopathy. We also agree
that the high prevalence of anterior TWI in asymp-
tomatic athletes suggests physiological remodeling in
most cases. However, these repolarization changes
probably represent the complex interplay between
structural, functional, and electrical remodeling
forces that we have yet to fully comprehend.Abbas Zaidi, MD
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